Rapid method for the determination of metamizole residues in bovine muscle by LC-MS/MS

被引:11
作者
Jedziniak, Piotr [1 ]
Pietruk, Konrad [1 ]
Sledzinska, Edyta [1 ]
Olejnik, Malgorzata [1 ]
Szprengier-Juszkiewicz, Teresa [1 ]
Zmudzki, Jan [1 ]
机构
[1] Natl Inst Vet Res, Dept Pharmacol & Toxicol, Pulawy, Poland
来源
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT | 2013年 / 30卷 / 06期
关键词
metamizole metabolites; dipyrone; residues; LC-MS/MS; ACTIVE METABOLITE; DIPYRONE; 4-METHYLAMINOANTIPYRINE; SPECTROMETRY;
D O I
10.1080/19440049.2013.787652
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Metamizole is a pyrazolone non-steroidal anti-inflammatory drug allowed for use in food-producing animals. According to Council Directive 96/23, residues of this drug have to be monitored because of the potential risk to consumers' health. Metamizole is hydrolysed to its marker residue 4-methylaminoantypyrine.This compound is further metabolised to three main metabolites: 4-formylaminoantipyrine, 4-aminoantipyrine and 4-acetylaminoantipyrine. The MRL of 4-methylaminoantipyrine in animal tissues is 100 mu gkg(-1). Considering the above points, a method for the detection of four metamizole metabolites in bovine muscles was developed. Analytes were extracted from muscle by a mixture of acetonitrile and sodium acetate buffer. After centrifugation, the supernatant was passed through alumina cartridges, diluted with mobile phase and analysed by using LC-MS/MS. Four metamizole metabolites were separated on a C8 column in 23min with a gradient of methanol:acetonitrile:ammonium formate solution and analysed by using positive ionisation. Validation of the method indicated a within-laboratory reproducibility in the range of 7-30% and recovery in the range of 45-95%. The method fulfils the criteria for confirmatory methods and, thanks to its labour efficiency, may also be used for screening purposes.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 14 条
[1]   Comparative safety evaluation of non-narcotic analgesics [J].
Andrade, SE ;
Martinez, C ;
Walker, AM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (12) :1357-1365
[2]  
[Anonymous], 2002, Commission Decision 2002/657/EC of
[3]  
European Commission and D. G. Health, 2001, MAA 001 CONF METH DE, P1
[4]  
European Commission No 37/2010, 2009, OFF J EUR UNION L, V15, P1
[5]  
European Medicine Agency, 1999, MET SUMM REP
[6]   Importance of MS selectivity and chromatographic separation in LC-MS/MS-based methods when investigating pharmaceutical metabolites in water. Dipyrone as a case of study [J].
Ibanez, M. ;
Gracia-Lor, E. ;
Sancho, J. V. ;
Hernandez, F. .
JOURNAL OF MASS SPECTROMETRY, 2012, 47 (08) :1040-1046
[7]   Determination of non-steroidal anti-inflammatory drugs and their metabolites in milk by liquid chromatography-tandem mass spectrometry [J].
Jedziniak, Piotr ;
Szprengier-Juszkiewicz, Teresa ;
Pietruk, Konrad ;
Sledzinska, Edyta ;
Zmudzki, Jan .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 403 (10) :2955-2963
[8]   Development of a rapid, multi-class method for the confirmatory analysis of anti-inflammatory drugs in bovine milk using liquid chromatography tandem mass spectrometry [J].
Malone, E. M. ;
Dowling, G. ;
Elliott, C. T. ;
Kennedy, D. G. ;
Regan, L. .
JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (46) :8132-8140
[9]   Quantification of 4-methylaminoantipyrine, the active metabolite of dipyrone, in human plasma [J].
Ojha, Ashwini ;
Rathod, Rajeshwari ;
Padh, Harish .
BIOANALYSIS, 2009, 1 (02) :293-298
[10]  
Penney L, 2005, J AOAC INT, V88, P496